8-HOUR BAYER Aspirin should be avoided during pregnancy, especially in the third trimester (risk of premature closure of ductus arteriosus, oligohydramnios, and bleeding). Low-dose aspirin (81 mg/day) may be used for high-risk conditions (e.g., preeclampsia prevention) under medical supervision. | NSAID | caution |
ACETAMINOPHEN AND IBUPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
ACETAMINOPHEN, ASPIRIN AND CAFFEINE Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections. | NSAID / Antiplatelet | avoid |
ACTRON Comprehensive clinical and safety monograph for ACTRON (ACTRON). | NSAID | caution |
ACULAR Comprehensive clinical and safety monograph for ACULAR (ACULAR). | NSAID Ophthalmic | caution |
ACULAR LS Comprehensive clinical and safety monograph for ACULAR LS (ACULAR LS). | NSAID Ophthalmic | caution |
ACULAR PRESERVATIVE FREE Comprehensive clinical and safety monograph for ACULAR PRESERVATIVE FREE (ACULAR PRESERVATIVE FREE). | NSAID Ophthalmic | caution |
ACUVAIL Comprehensive clinical and safety monograph for ACUVAIL (ACUVAIL). | NSAID Ophthalmic | caution |
ADVIL Comprehensive clinical and safety monograph for ADVIL (ADVIL). | NSAID | caution |
ADVIL ALLERGY AND CONGESTION RELIEF Comprehensive clinical and safety monograph for ADVIL ALLERGY AND CONGESTION RELIEF (ADVIL ALLERGY AND CONGESTION RELIEF). | NSAID/Decongestant Combination | caution |
ADVIL ALLERGY SINUS Comprehensive clinical and safety monograph for ADVIL ALLERGY SINUS (ADVIL ALLERGY SINUS). | NSAID/Decongestant/Antihistamine Combination | caution |
ADVIL COLD AND SINUS Comprehensive clinical and safety monograph for ADVIL COLD AND SINUS (ADVIL COLD AND SINUS). | NSAID/Decongestant Combination | caution |
ADVIL CONGESTION RELIEF Comprehensive clinical and safety monograph for ADVIL CONGESTION RELIEF (ADVIL CONGESTION RELIEF). | NSAID/Decongestant Combination | caution |
ADVIL DUAL ACTION WITH ACETAMINOPHEN Comprehensive clinical and safety monograph for ADVIL DUAL ACTION WITH ACETAMINOPHEN (ADVIL DUAL ACTION WITH ACETAMINOPHEN). | NSAID/Analgesic Combination | caution |
ADVIL LIQUI-GELS Comprehensive clinical and safety monograph for ADVIL LIQUI-GELS (ADVIL LIQUI-GELS). | NSAID | caution |
ADVIL MIGRAINE LIQUI-GELS Comprehensive clinical and safety monograph for ADVIL MIGRAINE LIQUI-GELS (ADVIL MIGRAINE LIQUI-GELS). | NSAID | caution |
ADVIL PM Comprehensive clinical and safety monograph for ADVIL PM (ADVIL PM). | NSAID/Sedative Combination | caution |
ALEVE Comprehensive clinical and safety monograph for ALEVE (ALEVE). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
ALEVE PM Comprehensive clinical and safety monograph for ALEVE PM (ALEVE PM). | NSAID/Antihistamine Combination | caution |
ALEVE-D SINUS & COLD Comprehensive clinical and safety monograph for ALEVE-D SINUS & COLD (ALEVE-D SINUS & COLD). | NSAID/Decongestant Combination | caution |
ANAPROX Comprehensive clinical and safety monograph for ANAPROX (ANAPROX). | NSAID | caution |
ANAPROX DS Comprehensive clinical and safety monograph for ANAPROX DS (ANAPROX DS). | NSAID | caution |
ANJESO Comprehensive clinical and safety monograph for ANJESO (ANJESO). | NSAID | caution |
ANSAID Comprehensive clinical and safety monograph for ANSAID (ANSAID). | NSAID | caution |
ARTHROTEC Comprehensive clinical and safety monograph for ARTHROTEC (ARTHROTEC). | NSAID | caution |
Aspirin Aspirin has a profoundly dose-dependent safety and indication profile in pregnancy that mandates clear clinical distinction between low-dose (75–100 mg/day, antiplatelet) and high-dose (≥325 mg, analgesic/anti-inflammatory) use. Low-dose aspirin (LDA) is a cornerstone intervention in obstetric medicine: ACOG, USPSTF (Grade B recommendation), WHO, NICE, and FIGO all recommend initiating LDA at 12–16 weeks gestation (optimally before 16 weeks, ideally by 12 weeks) in women at increased risk of preeclampsia, reducing its incidence by approximately 10–24% overall and by up to 62% when initiated before 16 weeks in high-risk women (ASPRE trial). LDA is also used for antiphospholipid syndrome (APS), prevention of recurrent pregnancy loss in APS, and thromboprophylaxis in specific haematological conditions. High-dose aspirin functions as a full NSAID and carries the class risks of premature closure of the ductus arteriosus (particularly after 20 weeks, critically so after 32 weeks), fetal renal impairment, oligohydramnios, inhibition of labour, and maternal and fetal haemostatic compromise. High-dose aspirin should be avoided after 20 weeks of gestation and is contraindicated after 32 weeks. The FDA issued a Drug Safety Communication in 2020 strengthening warnings against NSAID use (including high-dose aspirin) from 20 weeks onwards. | NSAID / Antiplatelet | caution |
AZOLID Comprehensive clinical and safety monograph for AZOLID (AZOLID). | NSAID | caution |
BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections. | NSAID / Antiplatelet | avoid |
BEXTRA Comprehensive clinical and safety monograph for BEXTRA (BEXTRA). | COX-2 Inhibitor NSAID | caution |
BROMDAY Comprehensive clinical and safety monograph for BROMDAY (BROMDAY). | Ophthalmic NSAID | caution |
BROMFENAC SODIUM Comprehensive clinical and safety monograph for BROMFENAC SODIUM (BROMFENAC SODIUM). | Ophthalmic NSAID | caution |
BROMSITE Comprehensive clinical and safety monograph for BROMSITE (BROMSITE). | Ophthalmic NSAID | caution |
BUTALBITAL, ASPIRIN AND CAFFEINE Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections. | NSAID / Antiplatelet | avoid |
BUTAZOLIDIN Comprehensive clinical and safety monograph for BUTAZOLIDIN (BUTAZOLIDIN). | NSAID | caution |
CALDOLOR Comprehensive clinical and safety monograph for CALDOLOR (CALDOLOR). | NSAID | caution |
CAMBIA Comprehensive clinical and safety monograph for CAMBIA (CAMBIA). | NSAID | caution |
CAP-PROFEN Comprehensive clinical and safety monograph for CAP-PROFEN (CAP-PROFEN). | Opioid and NSAID Combination | caution |
CELEBREX Comprehensive clinical and safety monograph for CELEBREX (CELEBREX). | NSAID (COX-2 Inhibitor) | caution |
CHILDREN'S ADVIL Comprehensive clinical and safety monograph for CHILDREN'S ADVIL (CHILDREN'S ADVIL). | NSAID | caution |
CHILDREN'S ADVIL-FLAVORED Comprehensive clinical and safety monograph for CHILDREN'S ADVIL-FLAVORED (CHILDREN'S ADVIL-FLAVORED). | NSAID | caution |
CHILDREN'S ELIXSURE Comprehensive clinical and safety monograph for CHILDREN'S ELIXSURE (CHILDREN'S ELIXSURE). | NSAID | caution |
CHILDREN'S IBUPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
CHILDREN'S MOTRIN Comprehensive clinical and safety monograph for CHILDREN'S MOTRIN (CHILDREN'S MOTRIN). | NSAID | caution |
CLINORIL Comprehensive clinical and safety monograph for CLINORIL (CLINORIL). | NSAID | caution |
COMBUNOX Comprehensive clinical and safety monograph for COMBUNOX (COMBUNOX). | Analgesic Combination (Opioid + NSAID) | caution |
COMPOUND 65 Comprehensive clinical and safety monograph for COMPOUND 65 (COMPOUND 65). | Analgesic Combination (Opioid + NSAID) | caution |
CONSENSI Comprehensive clinical and safety monograph for CONSENSI (CONSENSI). | Antihypertensive/NSAID Combination | caution |
COXANTO Comprehensive clinical and safety monograph for COXANTO (COXANTO). | NSAID | caution |
DAYPRO Comprehensive clinical and safety monograph for DAYPRO (DAYPRO). | Nonsteroidal Anti-Inflammatory Drug (NSAID) | caution |
DAYPRO ALTA Comprehensive clinical and safety monograph for DAYPRO ALTA (DAYPRO ALTA). | Nonsteroidal Anti-Inflammatory Drug (NSAID) | caution |
DICLOFENAC ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
DICLOFENAC POTASSIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
DICLOFENAC SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
DIFLUNISAL Comprehensive clinical and safety monograph for DIFLUNISAL (DIFLUNISAL). | NSAID | caution |
DUEXIS Comprehensive clinical and safety monograph for DUEXIS (DUEXIS). | NSAID/H2 Antagonist Combination | caution |
DYCLOPRO Comprehensive clinical and safety monograph for DYCLOPRO (DYCLOPRO). | NSAID | caution |
DYLOJECT Comprehensive clinical and safety monograph for DYLOJECT (DYLOJECT). | NSAID | caution |
EC-NAPROSYN Comprehensive clinical and safety monograph for EC-NAPROSYN (EC-NAPROSYN). | NSAID | caution |
ELYXYB Comprehensive clinical and safety monograph for ELYXYB (ELYXYB). | NSAID (COX-2 Inhibitor) | caution |
ETODOLAC ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
ETYQA Comprehensive clinical and safety monograph for ETYQA (ETYQA). | COX-2 Inhibitor NSAID | caution |
EYDENZELT Comprehensive clinical and safety monograph for EYDENZELT (EYDENZELT). | NSAID | caution |
FENOPROFEN CALCIUM Comprehensive clinical and safety monograph for FENOPROFEN CALCIUM (FENOPROFEN CALCIUM). | NSAID | caution |
FLECTOR Comprehensive clinical and safety monograph for FLECTOR (FLECTOR). | Topical NSAID | caution |
FLURBIPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
FLURBIPROFEN SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
FYAVOLV Comprehensive clinical and safety monograph for FYAVOLV (FYAVOLV). | Topical NSAID | caution |
HYDROCODONE BITARTRATE AND IBUPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
IBTROZI Comprehensive clinical and safety monograph for IBTROZI (IBTROZI). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
IBU Comprehensive clinical and safety monograph for IBU (IBU). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
IBU-TAB Comprehensive clinical and safety monograph for IBU-TAB (IBU-TAB). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
IBU-TAB 200 Comprehensive clinical and safety monograph for IBU-TAB 200 (IBU-TAB 200). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
IBUPRIN Comprehensive clinical and safety monograph for IBUPRIN (IBUPRIN). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
Ibuprofen Avoid, especially after 20 weeks gestation. Associated with premature closure of the ductus arteriosus and fetal renal dysfunction leading to oligohydramnios. The FDA strengthened its warning in 2020 to include all NSAIDs from 20 weeks onward. Some studies suggest a modest increase in early miscarriage risk with first-trimester use, though evidence is not definitive. | NSAID | avoid |
IBUPROFEN AND DIPHENHYDRAMINE CITRATE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
IBUPROFEN AND FAMOTIDINE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
IBUPROFEN LYSINE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
IBUPROFEN SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
IBUPROHM Comprehensive clinical and safety monograph for IBUPROHM (IBUPROHM). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
IBUPROHM COLD AND SINUS Comprehensive clinical and safety monograph for IBUPROHM COLD AND SINUS (IBUPROHM COLD AND SINUS). | NSAID/Decongestant Combination | caution |
ILEVRO Comprehensive clinical and safety monograph for ILEVRO (ILEVRO). | Ophthalmic NSAID | caution |
INDICLOR Comprehensive clinical and safety monograph for INDICLOR (INDICLOR). | NSAID | caution |
INDO-LEMMON Comprehensive clinical and safety monograph for INDO-LEMMON (INDO-LEMMON). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
INDOCIN Comprehensive clinical and safety monograph for INDOCIN (INDOCIN). | NSAID | caution |
INDOCIN SR Comprehensive clinical and safety monograph for INDOCIN SR (INDOCIN SR). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
INDOMETHACIN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
INDOMETHACIN SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
INFANT'S ADVIL Comprehensive clinical and safety monograph for INFANT'S ADVIL (INFANT'S ADVIL). | NSAID | caution |
IVRA Comprehensive clinical and safety monograph for IVRA (IVRA). | Nonsteroidal Anti-Inflammatory Drug (NSAID) | caution |
JUNIOR STRENGTH ADVIL Comprehensive clinical and safety monograph for JUNIOR STRENGTH ADVIL (JUNIOR STRENGTH ADVIL). | NSAID Analgesic | caution |
JUNIOR STRENGTH IBUPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
JUNIOR STRENGTH MOTRIN Comprehensive clinical and safety monograph for JUNIOR STRENGTH MOTRIN (JUNIOR STRENGTH MOTRIN). | NSAID Analgesic | caution |
KETOPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
KETOROLAC TROMETHAMINE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious bleeding and renal impairment. | NSAID | avoid |
KETOROLAC TROMETHAMINE AND PHENYLEPHRINE HYDROCHLORIDE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious bleeding and renal impairment. | NSAID | avoid |
LODINE Comprehensive clinical and safety monograph for LODINE (LODINE). | NSAID | caution |
LODINE XL Comprehensive clinical and safety monograph for LODINE XL (LODINE XL). | NSAID | caution |
MEASURIN Comprehensive clinical and safety monograph for MEASURIN (MEASURIN). | NSAID | caution |
MECLOFENAMATE SODIUM Comprehensive clinical and safety monograph for MECLOFENAMATE SODIUM (MECLOFENAMATE SODIUM). | NSAID | caution |
MECLOMEN Comprehensive clinical and safety monograph for MECLOMEN (MECLOMEN). | NSAID | caution |
MEFENAMIC ACID ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
MELOXICAM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
MEPRO-ASPIRIN Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections. | NSAID / Antiplatelet | avoid |
MEPROBAMATE AND ASPIRIN Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections. | NSAID / Antiplatelet | avoid |
MOTRIN Comprehensive clinical and safety monograph for MOTRIN (MOTRIN). | NSAID Analgesic | caution |
MOTRIN IB Comprehensive clinical and safety monograph for MOTRIN IB (MOTRIN IB). | NSAID Analgesic | caution |
MOTRIN MIGRAINE PAIN Comprehensive clinical and safety monograph for MOTRIN MIGRAINE PAIN (MOTRIN MIGRAINE PAIN). | NSAID Analgesic | caution |
NABUMETONE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
NALFON Comprehensive clinical and safety monograph for NALFON (NALFON). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
NAPRELAN Comprehensive clinical and safety monograph for NAPRELAN (NAPRELAN). | NSAID | caution |
NAPROSYN Comprehensive clinical and safety monograph for NAPROSYN (NAPROSYN). | NSAID | caution |
NAPROXEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
NAPROXEN SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
NEOPROFEN Comprehensive clinical and safety monograph for NEOPROFEN (NEOPROFEN). | NSAID | caution |
NEVANAC Comprehensive clinical and safety monograph for NEVANAC (NEVANAC). | NSAID Ophthalmic | caution |
OCUFEN Comprehensive clinical and safety monograph for OCUFEN (OCUFEN). | Ophthalmic NSAID | caution |
OMIDRIA Comprehensive clinical and safety monograph for OMIDRIA (OMIDRIA). | Ophthalmic NSAID and Mydriatic Combination | caution |
ONMEL Comprehensive clinical and safety monograph for ONMEL (ONMEL). | NSAID | caution |
ORUDIS Comprehensive clinical and safety monograph for ORUDIS (ORUDIS). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
ORUDIS KT Comprehensive clinical and safety monograph for ORUDIS KT (ORUDIS KT). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
ORUVAIL Comprehensive clinical and safety monograph for ORUVAIL (ORUVAIL). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
OXAPROZIN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
PEDIATRIC ADVIL Comprehensive clinical and safety monograph for PEDIATRIC ADVIL (PEDIATRIC ADVIL). | NSAID | caution |
PENNSAID Comprehensive clinical and safety monograph for PENNSAID (PENNSAID). | Topical NSAID | caution |
PHENYLBUTAZONE Comprehensive clinical and safety monograph for PHENYLBUTAZONE (PHENYLBUTAZONE). | NSAID | caution |
PIROXICAM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
PREVACID NAPRAPAC 250 (COPACKAGED) Comprehensive clinical and safety monograph for PREVACID NAPRAPAC 250 (COPACKAGED) (PREVACID NAPRAPAC 250 (COPACKAGED)). | Proton Pump Inhibitor/NSAID Combination | caution |
PREVACID NAPRAPAC 375 (COPACKAGED) Comprehensive clinical and safety monograph for PREVACID NAPRAPAC 375 (COPACKAGED) (PREVACID NAPRAPAC 375 (COPACKAGED)). | Proton Pump Inhibitor/NSAID Combination | caution |
PREVACID NAPRAPAC 500 (COPACKAGED) Comprehensive clinical and safety monograph for PREVACID NAPRAPAC 500 (COPACKAGED) (PREVACID NAPRAPAC 500 (COPACKAGED)). | Proton Pump Inhibitor/NSAID Combination | caution |
PROFENAL Comprehensive clinical and safety monograph for PROFENAL (PROFENAL). | NSAID | caution |
PROLENSA Comprehensive clinical and safety monograph for PROLENSA (PROLENSA). | Ophthalmic NSAID | caution |
PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections. | NSAID / Antiplatelet | avoid |
RELAFEN Comprehensive clinical and safety monograph for RELAFEN (RELAFEN). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
RIMADYL Comprehensive clinical and safety monograph for RIMADYL (RIMADYL). | Nonsteroidal Anti-inflammatory Drug (NSAID) | caution |
RUFEN Comprehensive clinical and safety monograph for RUFEN (RUFEN). | Nonsteroidal Anti-Inflammatory Drug (NSAID) | caution |
SINE-AID IB Comprehensive clinical and safety monograph for SINE-AID IB (SINE-AID IB). | Combination NSAID/antihistamine | caution |
SOLARAZE Comprehensive clinical and safety monograph for SOLARAZE (SOLARAZE). | NSAID | caution |
SPRIX Comprehensive clinical and safety monograph for SPRIX (SPRIX). | NSAID Analgesic | caution |
SULINDAC ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
TAB-PROFEN Comprehensive clinical and safety monograph for TAB-PROFEN (TAB-PROFEN). | NSAID | caution |
TENATHAN Comprehensive clinical and safety monograph for TENATHAN (TENATHAN). | NSAID | caution |
TOLECTIN Comprehensive clinical and safety monograph for TOLECTIN (TOLECTIN). | NSAID | caution |
TOLECTIN 600 Comprehensive clinical and safety monograph for TOLECTIN 600 (TOLECTIN 600). | NSAID | caution |
TOLECTIN DS Comprehensive clinical and safety monograph for TOLECTIN DS (TOLECTIN DS). | NSAID | caution |
TOLMETIN SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding. | NSAID | avoid |
TORADOL Comprehensive clinical and safety monograph for TORADOL (TORADOL). | NSAID (Ketorolac) | caution |
VAZALORE Comprehensive clinical and safety monograph for VAZALORE (VAZALORE). | NSAID | caution |
VIMOVO Comprehensive clinical and safety monograph for VIMOVO (VIMOVO). | NSAID/PPI Combination | caution |
VIOXX Comprehensive clinical and safety monograph for VIOXX (VIOXX). | NSAID (COX-2 Inhibitor) | caution |
VIVLODEX Comprehensive clinical and safety monograph for VIVLODEX (VIVLODEX). | NSAID | caution |
VOLTAREN Comprehensive clinical and safety monograph for VOLTAREN (VOLTAREN). | NSAID | caution |
VOLTAREN ARTHRITIS PAIN Comprehensive clinical and safety monograph for VOLTAREN ARTHRITIS PAIN (VOLTAREN ARTHRITIS PAIN). | NSAID (Topical) | caution |
VOLTAREN-XR Comprehensive clinical and safety monograph for VOLTAREN-XR (VOLTAREN-XR). | NSAID | caution |
XIBROM Comprehensive clinical and safety monograph for XIBROM (XIBROM). | NSAID | caution |
ZIPSOR Comprehensive clinical and safety monograph for ZIPSOR (ZIPSOR). | NSAID | caution |
ZORVOLEX Comprehensive clinical and safety monograph for ZORVOLEX (ZORVOLEX). | NSAID | caution |
ZYNRELEF KIT Comprehensive clinical and safety monograph for ZYNRELEF KIT (ZYNRELEF KIT). | Local Anesthetic and NSAID Combination | caution |
